Early Postpartum Intrauterine Device (IUD) Placement

Stopped early · Phase 4

Conditions studied: Contraception

In brief

Women who have just given birth are at high risk for rapid repeat pregnancy, which can lead to negative consequences during the subsequent pregnancy. Providers have traditionally delayed starting birth control, especially placement of intrauterine devices (IUDs), post-delivery for a number of reasons. The first postpartum visit after a woman has given birth is typically scheduled for 6 weeks after her delivery, during which she is typically provided with her chosen method of birth control. This study will evaluate two different IUD placement times: 3 weeks and 6 weeks after delivery. This will allow the researchers to determine if placement time affects a woman's follow-through obtaining the IUD and keeping it inserted in place. The researchers will also look at bleeding patterns and patient/provider satisfaction with the IUD placement

Key facts

Study ID

NCT01594476

Run by

Oregon Health and Science University

People needed

201

Starts

2012-03-01

Expected to finish

2014-07-01

Last updated by the study team

2019-01-11

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female
• 18 years or older
• Voluntarily requesting either copper T380A or levonorgestrel IUD placement for postpartum contraception
• Within 5 days of vaginal or cesarean delivery of live born infant ≥32 0/7 weeks at the time of enrollment
• English or Spanish speaking
• Able to give consent and agree to terms of the study
• No contraindications to use of either intrauterine device

You may not qualify if…

• Preterm delivery prior to 32 weeks gestation
• Recent pregnancy with multiple gestation
• Current incarceration
• Known congenital or acquired uterine anomaly, including fibroids that distort the uterine cavity
• Current or recent pelvic infection (chorioamnionitis treated for fever in labor only is not an exclusion)
• Suspected hypersensitivity or contraindication to the chosen IUD
• No insurance coverage for postpartum care, including Citizen Alien Waived Emergent Medical (CAWEM)

Where it is running

• Oregon Health & Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.